MGLMX
Price
$16.63
Change
+$0.05 (+0.30%)
Updated
Dec 3 closing price
Net Assets
2.2B
POSIX
Price
$9.86
Change
-$0.00 (-0.00%)
Updated
Dec 3 closing price
Net Assets
1.6B
Interact to see
Advertisement

MGLMX vs POSIX

Header iconMGLMX vs POSIX Comparison
Open Charts MGLMX vs POSIXBanner chart's image
MFS Global Real Estate R4
Price$16.63
Change+$0.05 (+0.30%)
VolumeN/A
Net Assets2.2B
Principal Global Real Estate Sec Instl
Price$9.86
Change-$0.00 (-0.00%)
VolumeN/A
Net Assets1.6B
MGLMX vs POSIX Comparison Chart in %
View a ticker or compare two or three
VS
MGLMX vs. POSIX commentary
Dec 05, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MGLMX is a Buy and POSIX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
MGLMX has more cash in the bank: 2.2B vs. POSIX (1.6B). MGLMX pays higher dividends than POSIX: MGLMX (2.48) vs POSIX (2.34). MGLMX was incepted earlier than POSIX: MGLMX (11 years) vs POSIX (18 years). POSIX (1.01) is less costly to investors than MGLMX (0.95). MGLMX is a more actively managed with annual turnover of: 48.00 vs. POSIX (27.50). MGLMX (0) and POSIX (0) have matching initial minimum investment requirements. POSIX annual gain was more profitable for investors over the last year : 2.03 vs. MGLMX (-3.00). POSIX return over 5 years is better than : 10.09 vs. MGLMX (1.78).
MGLMXPOSIXMGLMX / POSIX
Total Expense Ratio0.940.9599%
Annual Report Gross Expense Ratio0.951.0194%
Fund Existence11 years18 years-
Gain YTD3.5498.11444%
Front LoadN/AN/A-
Min. Initial Investment00-
Min. Initial Investment IRAN/AN/A-
Net Assets2.2B1.6B137%
Annual Yield % from dividends2.482.34106%
Returns for 1 year-3.002.03-148%
Returns for 3 years2.9916.8718%
Returns for 5 years1.7810.0918%
Returns for 10 years24.7435.4470%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
CPOCX19.270.47
+2.50%
Morgan Stanley Insight L
DTCAX21.060.04
+0.19%
BNY Mellon Sust US Equity A
PCAQX92.620.09
+0.10%
Principal Capital Appreciation R5
IPHYF1.99N/A
N/A
Innate Pharma
PRPRF0.02N/A
N/A
Prairie Provident Resources Inc